Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bendelac

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
European Journal of Immunology|March 1, 1993
Evidence for a preferential V beta usage by the T cells which adoptively transfer diabetes in NOD miceP Edouard, C Thivolet, P Bedossa, et al.
American Journal of Respiratory Cell and Molecular Biology|August 2, 2000
A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lungC D D'Souza, A M Cooper, A A Frank, et al.
Chemical Science|April 1, 2014
A peptide-free, liposome-based oligosaccharide vaccine, adjuvanted with a natural killer T cell antigen, generates robust antibody responses <i>in vivo.</i>S Deng, L Bai, R Reboulet, et al.
The Journal of Experimental Medicine|November 17, 1998
Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetesA Lehuen, O Lantz, L Beaudoin, et al.
Chemical Science|May 17, 2017
Psychosine variants as antigens for natural killer T cellsS Deng, L Kain, C S Pereira, et al.
Cancer|September 1, 1987
Nonneoplastic circulating Sézary-like cells in cutaneous T-cell lymphoma. Ultrastructural, immunologic, and T-cell receptor gene-rearrangement studiesA Bendelac, N T O'Connor, M T Daniel, et al.
Journal of the American Academy of Dermatology|October 1, 1986
Cutaneous pheomorphic T cell lymphoma. Immunologic, virologic, and T-cell receptor gene rearrangement studies in one European case with initial pseudolymphoma presentationA Bendelac, P Lesavre, C Boitard, et al.
The Journal of Experimental Medicine|June 22, 1999
An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammalsF Tilloy, E Treiner, S H Park, et al.
The Journal of Experimental Medicine|October 17, 2001
Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma productionY Ikarashi, R Mikami, A Bendelac, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2000
alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malariaG Gonzalez-Aseguinolaza, C de Oliveira, M Tomaska, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
European Journal of Immunology|March 1, 1993
Evidence for a preferential V beta usage by the T cells which adoptively transfer diabetes in NOD miceP Edouard, C Thivolet, P Bedossa, et al.
American Journal of Respiratory Cell and Molecular Biology|August 2, 2000
A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lungC D D'Souza, A M Cooper, A A Frank, et al.
Chemical Science|April 1, 2014
A peptide-free, liposome-based oligosaccharide vaccine, adjuvanted with a natural killer T cell antigen, generates robust antibody responses <i>in vivo.</i>S Deng, L Bai, R Reboulet, et al.
The Journal of Experimental Medicine|November 17, 1998
Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetesA Lehuen, O Lantz, L Beaudoin, et al.
Chemical Science|May 17, 2017
Psychosine variants as antigens for natural killer T cellsS Deng, L Kain, C S Pereira, et al.
Cancer|September 1, 1987
Nonneoplastic circulating Sézary-like cells in cutaneous T-cell lymphoma. Ultrastructural, immunologic, and T-cell receptor gene-rearrangement studiesA Bendelac, N T O'Connor, M T Daniel, et al.
Journal of the American Academy of Dermatology|October 1, 1986
Cutaneous pheomorphic T cell lymphoma. Immunologic, virologic, and T-cell receptor gene rearrangement studies in one European case with initial pseudolymphoma presentationA Bendelac, P Lesavre, C Boitard, et al.
The Journal of Experimental Medicine|June 22, 1999
An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammalsF Tilloy, E Treiner, S H Park, et al.
The Journal of Experimental Medicine|October 17, 2001
Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma productionY Ikarashi, R Mikami, A Bendelac, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2000
alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malariaG Gonzalez-Aseguinolaza, C de Oliveira, M Tomaska, et al.
Pageof 7